Juhani Knuuti profile picture
Juhani
Knuuti
Director, Turku PET Centre
InFLAMES Flagship
MD, professor, Turku PET Centre
Cardiovascular diseases, imaging

Contact

+358 29 450 2345
+358 50 059 2998
Kiinamyllynkatu 4-8
20520
Turku

Biography

Juhani Knuuti’s research has focused on the physiology and pathophysiology, diagnosis and new therapies of coronary artery disease, heart failure and metabolic diseases. The research is also focused on developing and utilizing novel noninvasive imaging methods (PET, SPECT, echocardiography, MRI and CT) that will help to determine the risk and severity of CHD and heart failure and provide guidance for therapy decisions. The recent focus in cardiac research has been on vulnerable plaques, cardiac remodelling and multimodality and hybrid imaging. In metabolic and diabetes research, the focus has been in the interactions between different organs and heart in the pathogenesis and development of the cardiac diseases.

Publications

Sort by:

A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome (2021)

Atherosclerosis
Di Giorgi Nicoletta, Michelucci Elena, Smit Jeff M., Scholte Arthur J.H.A., El Mahdiui Mohammed, Knuuti Juhani, Buechel Ronny R., Teresinska Anna, Pizzi Maria N., Roque Albert, Poddighe Rosa, Parodi Oberdan, Pelosi Gualtiero, Caselli Chiara, Neglia Danilo, Rocchiccioli Silvia
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Assessment of myocardial viability with [15O]water PET: A validation study in experimental myocardial infarction (2021)

Journal of Nuclear Cardiology
Maria Grönman, Miikka Tarkia, Christoffer Stark, Tommi Vähäsilta, Tuomas Kiviniemi, Mark Lubberink, Paavo Halonen, Antti Kuivanen, Virva Saunavaara, Tuula Tolvanen, Jarmo Teuho, Mika Teräs, Timo Savunen, Mikko Pietilä, Seppo Ylä-Herttuala, Anne Roivainen, Juhani Knuuti, Antti Saraste
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

First-in-Human Study of 68 Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1 (2021)

Journal of Nuclear Medicine
Viitanen Riikka, Moisio Olli Antero, Lankinen Petteri, Li Xiang-Guo, Koivumäki Mikko, Suilamo Sami, Tolvanen Tuula, Taimen Kirsi, Mali Markku, Kohonen Ia, Koskivirta Ilpo, Oikonen Vesa, Virtanen Helena, Santalahti Kristiina, Autio Anu, Saraste Antti, Pirilä Laura, Nuutila Pirjo, Knuuti Juhani, Jalkanen Sirpa, Roivainen Anne
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))